Bipolar disorder is a psychiatric illness that is commonly regarded as a spectrum of disorders characterized by fluctuating periods of depression and episodes of elevated mood and flights of fantasy (often referred to as mania). While there are drugs approved to treat both the manic and the depressive phases of this illness, there are still a significant number of people for which the response is less than optimal. As such, there is a significant unmet need.
To this end, SPRI has been recruited by a well-known pharmaceutical company to assist them in the conduct of a clinical trial designed to evaluate the potential effectiveness of a drug to specifically treat the depression associated with the subclass of bipolar disorders known as Bipolar I Depression. The drug under evaluation has already been approved by the FDA to treat other psychiatric indications.
Are you or someone you know …
➢ Is between18 and 65 years of age,
➢ Been diagnosed as someone suffering from Bipolar 1 Disorder,
➢ Is currently depressed, and
➢ Have experienced at least one manic episode
➢ Note: Additional inclusion and exclusion criteria apply
Participation is strictly confidential. Study medication, and study-related visits, procedures and tests are offered free of charge. We also offer limited financial compensation, as well as reimbursement to cover reasonable food and travel-related expenses.
If you wish to volunteer or learn more about what is involved in participating in this clinical trial or wish to see if you qualify to participate, please call 718-616-2400 or click the Contact US button below to send us an email.